NCT03278106
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Stage IIIA Gallbladder Cancer AJCC v7
Explore clinical trials studying Stage IIIA Gallbladder Cancer AJCC v7. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Stage IIIA Gallbladder Cancer AJCC v7 trial results
NCT02520141
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02392637
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +19 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
NCT03257761
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States